{"id":30025,"date":"2023-01-12T00:15:00","date_gmt":"2023-01-11T16:15:00","guid":{"rendered":"https:\/newsletter.sinica.edu.tw\/?p=30025"},"modified":"2023-05-03T15:12:42","modified_gmt":"2023-05-03T07:12:42","slug":"%e3%80%90%e5%b0%88%e6%ac%84%e3%80%91%e7%95%b6%e4%ba%ba%e9%a1%9e%e9%81%87%e8%a6%8b%e6%96%b0%e5%9e%8b%e5%86%a0%e7%8b%80%e7%97%85%e6%af%92-%e6%98%af%e6%ad%bb%e4%ba%a1%e6%88%96%e5%8a%a0","status":"publish","type":"post","link":"https:\/newsletter.sinica.edu.tw\/30025\/","title":{"rendered":"\u3010\u5c08\u6b04\u3011\u7576\u4eba\u985e\u9047\u898b\u65b0\u578b\u51a0\u72c0\u75c5\u6bd2 \u2014\u2014 \u662f\u6b7b\u4ea1\u6216\u52a0\u5195\uff1f"},"content":{"rendered":"

\u81ea\u958b\u5929\u95e2\u5730\u4ee5\u4f86\uff0c\u4eba\u985e\u7d93\u6b77\u4e0d\u540c\u6642\u671f\u751f\u6d3b\u578b\u614b\u7684\u8f49\u63db\uff0c\u7121\u8ad6\u662f\u72e9\u7375\u63a1\u96c6\u3001\u8fb2\u696d\u751f\u6d3b\uff0c\u9762\u5c0d\u7121\u6240\u4e0d\u5728\u7684\u75c5\u83cc\u4e14\u91ab\u85e5\u5c1a\u672a\u767c\u5c55\u4e4b\u6642\uff0c\u662f\u4ec0\u9ebc\u5951\u6a5f\u8b93\u4eba\u985e\u5b58\u6d3b\u7e41\u884d\uff0c\u800c\u4e0d\u81f3\u65bc\u6ec5\u7d55\uff1f<\/p>\n

\u9019\u53ef\u4ee5\u5f9e\u5404\u500b\u5b78\u9580\u9032\u884c\u8a0e\u8ad6\uff0c\u5c0d\u65bc\u79d1\u5b78\u5bb6\u800c\u8a00\uff0c\u300c\u514d\u75ab\u7cfb\u7d71\u300d\u662f\u5176\u4e2d\u4e00\u500b\u89e3\u91cb\u3002\u4eba\u9ad4\u6700\u5ee3\u6cdb\u7684\u514d\u75ab\u7cfb\u7d71\u662f\u76ae\u819a\uff0c\u6700\u5148\u62b5\u79a6\u5916\u5728\u75c5\u539f\u83cc\u7684\u76f4\u63a5\u63a5\u89f8\uff1b\u9664\u6b64\u4e4b\u5916\uff0c\u6211\u5011\u53ef\u80fd\u4e5f\u6703\u628a\u547c\u5438\u9053\u75c5\u539f\u83cc\u5438\u9032\u80ba\u88e1\uff0c\u9020\u6210\u5e38\u898b\u7684\u547c\u5438\u9053\u75c7\u72c0\u3001\u652f\u6c23\u7ba1\u708e\u6216\u80ba\u708e\uff0c\u9f3b\u6bdb\u505a\u70ba\u7b2c\u4e00\u5c64\u62b5\u79a6\u7684\u5c4f\u969c\uff0c\u53ef\u4ee5\u904e\u6ffe\u75c5\u539f\u83cc\u8207\u9ad2\u6c59\uff1b\u547c\u5438\u9053\u4e2d\u5713\u67f1\u578b\u7684\u4e0a\u76ae\u7d30\u80de\u4e5f\u6f14\u5316\u6210\u5177\u6709\u7e96\u6bdb\u7684\u69cb\u9020\uff0c\u6383\u9664\u547c\u5438\u9053\u4e2d\u7684\u5927\u5c0f\u9846\u7c92\uff1b\u5c1a\u672a\u88ab\u6383\u5730\u51fa\u9580\u7684\u547c\u5438\u9053\u75c5\u539f\u83cc\uff0c\u4fbf\u6703\u4f3a\u6a5f\u7684\u611f\u67d3\u4e0a\u76ae\u7d30\u80de\uff0c\u53e6\u4eba\u805e\u4e4b\u8272\u8b8a\u7684\u65b0\u578b\u51a0\u72c0\u75c5\u6bd2\u4e3b\u8981\u4fbf\u662f\u85c9\u7531\u53e3\u3001\u9f3b\u9032\u5165\u547c\u5438\u7cfb\u7d71\u4e26\u4e14\u641c\u5c0b\u5177\u6709 ACE2 \u53d7\u9ad4\u7684\u7d30\u80de\uff0c\u50cf\u662f\u547c\u5438\u9053\u4e0a\u76ae\u7d30\u80de\uff0c\u9032\u884c\u611f\u67d3\u3002<\/p>\n

\u75c5\u6bd2\u9032\u5165\u7d30\u80de\u5f8c\uff0c\u4fbf\u8086\u7121\u5fcc\u619a\u7684\u62c6\u89e3\u5404\u500b\u90e8\u4f4d\uff0c\u85c9\u7531\u81ea\u8eab\u651c\u5e36\u7684 RNA \u4f9d\u8cf4 RNA \u805a\u5408\u9176\uff08RNA dependent RNA polymerase\uff09\u9032\u884c\u672c\u9ad4 RNA \u57fa\u56e0\u8907\u88fd\uff0c\u8207\u75c5\u6bd2\u86cb\u767d\u8cea\u7684\u8f49\u9304\u8207\u8f49\u8b6f\uff0c\u9ce9\u4f54\u9d72\u5de2\u7684\u5229\u7528\u5bbf\u4e3b\u7d30\u80de\u7684\u80de\u5668\u9032\u884c\u75c5\u6bd2\u86cb\u767d\u8cea\u7684\u4fee\u98fe\u3002\u6700\u7d42\uff0c\u6210\u5343\u4e0a\u842c\u7d44\u88dd\u5b8c\u5584\u7684\u75c5\u6bd2\u9846\u7c92\u7531\u5bbf\u4e3b\u7d30\u80de\u7834\u7e6d\u800c\u51fa\uff0c\u518d\u5ea6\u611f\u67d3\u5468\u906d\u7684\u7d30\u80de\u3002<\/p>\n

\u5bbf\u4e3b\u7d30\u80de\u7684\u53cd\u64b2\uff1a\u5148\u5929\u6027\u8207\u9069\u61c9\u6027\u514d\u75ab\u53cd\u61c9<\/strong><\/p>\n

\u53d7\u611f\u67d3\u4e4b\u7d30\u80de\u85c9\u7531 TLR \uff08Toll like receptor\uff09\u8fa8\u8b58\u5230\u4e86\u75c5\u6bd2 RNA\uff0c\u56e0\u800c\u8a98\u767c\u4e00\u7cfb\u5217\u4e4b\u8a0a\u865f\u50b3\u905e\uff0c\u89f8\u767c\u5e72\u64fe\u7d20\uff08IFN, interferon\uff09\u8207\u5176\u4ed6\u7d30\u80de\u6fc0\u7d20\uff0c\u4f8b\u5982\uff1aTNF-\u03b1\u3001IL-6 \u8207 IL-18 \u7684\u91cb\u653e\uff0c\u4f86\u62b5\u79a6\u75c5\u6bd2\u7684\u611f\u67d3\uff1b\u53e6\u4e00\u65b9\u9762\u7d30\u80de\u6fc0\u7d20\u4e5f\u53ef\u80fd\u662f\u7531\u6a39\u7a81\u7d30\u80de\u3001\u5de8\u566c\u7d30\u80de\u7b49\u9019\u4e9b\u885b\u5175\u7d30\u80de\u541e\u566c\u75c5\u6bd2\u5f8c\u6240\u91cb\u653e\u3002\u9019\u4e9b\u53cd\u61c9\u5c6c\u65bc\u300c\u5148\u5929\u6027\u514d\u75ab\u53cd\u61c9\u300d\u7684\u7bc4\u7587\u3002\u9762\u5c0d\u4f86\u52e2\u5147\u731b\u7684\u75c5\u6bd2\uff0c\u5148\u5929\u6027\u514d\u75ab\u53cd\u61c9\u4f86\u5f97\u53c8\u6025\u53c8\u5feb\uff0c\u4f46\u7f3a\u4e4f\u7279\u7570\u6027\u8207\u8a18\u61b6\u6027\uff0c\u7121\u6cd5\u63d0\u4f9b\u9577\u4e45\u7684\u4fdd\u8b77\u3002\u5148\u5929\u6027\u514d\u75ab\u7684\u885b\u5175\u7d30\u80de\u541e\u566c\u75c5\u6bd2\u5f8c\uff0c\u6703\u5448\u73fe\u75c5\u6bd2\u7684\u7247\u6bb5\u76f4\u63a5\u6216\u9593\u63a5\u7684\u6d3b\u5316 T \u7d30\u80de\uff0c\u6d3b\u5316\u7684 TC \u7d30\u80de\u6703\u64b2\u6bba\u5448\u73fe\u75c5\u6bd2\u7247\u6bb5\uff08\u6297\u539f\uff09\u7684\u7d30\u80de\uff1b\u53e6\u4e00\u65b9\u9762\uff0c\u6d3b\u5316\u7684 TH \u7d30\u80de\uff0c\u5247\u6703\u8a98\u767c B \u7d30\u80de\u9032\u5316\u70ba\u6f3f\u7d30\u80de\u7522\u751f\u7279\u7570\u6027\u6297\u9ad4\u3002\u800c B \u7d30\u80de\u662f\u5177\u6709\u8a18\u61b6\u6027\u7684\uff0c\u9762\u5c0d\u76f8\u4f3c\u7684\u5916\u4f86\u8005\uff0cB \u7d30\u80de\u53ef\u8fc5\u901f\u7684\u53cd\u61c9\u751f\u7522\u5c0d\u6297\u65b0\u578b\u51a0\u72c0\u75c5\u6bd2\u8868\u9762\u68d8\u86cb\u767d\u6297\u9ad4\uff0c\u963b\u64cb\u75c5\u6bd2\u8207 ACE \u53d7\u9ad4\u7684\u8fa8\u8b58\u6216\u8207\u5148\u5929\u6027\u514d\u75ab\u7d30\u80de\u806f\u5408\u64b2\u6bba\u75c5\u539f\u83cc\u3002<\/p>\n

\u5148\u5929\u8207\u5f8c\u5929\u514d\u75ab\u7cfb\u7d71\u5b8c\u7f8e\u7684\u642d\u914d\uff0c\u4fdd\u8b77\u4e86\u4eba\u985e\u62b5\u79a6\u4e86\u8a31\u591a\u75c5\u539f\u83cc\u611f\u67d3\uff0c\u4f7f\u4eba\u985e\u4e0d\u662f\u90a3\u9ebc\u7684\u4e0d\u582a\u4e00\u64ca\u3002\u800c\u300c\u75ab\u82d7\u300d\uff0c\u5247\u7531\u4eba\u70ba\u7684\u65b9\u5f0f\u88fd\u4f5c\u6210\u514d\u75ab\u539f\uff0c\u4f7f\u4eba\u9ad4\u9810\u5148\u8fa8\u8b58\u75c5\u539f\u83cc\u8868\u9762\u86cb\u767d\u8cea\u56e0\u800c\u7522\u751f\u7279\u7570\u6027\u6297\u9ad4\uff0c\u9810\u9632\u5373\u5c07\u5230\u4f86\u7684\u75c5\u539f\u83cc\u611f\u67d3\u3002<\/p>\n

\u65b0\u578b\u51a0\u72c0\u75c5\u6bd2\u7684\u6c42\u751f\u6b32<\/strong><\/p>\n

\u5c0d\u65bc\u6240\u6709\u7269\u7a2e\u4f86\u8aaa\uff0c\u7e41\u884d\u90fd\u662f\u4ef6\u91cd\u8981\u7684\u4e8b\uff0c\u75c5\u6bd2\u4e5f\u4e0d\u4f8b\u5916\u3002\u8b93\u5bbf\u4e3b\u7d30\u80de\u4e0d\u65b7\u7684\u70ba\u81ea\u5df1\u9032\u884c\u8907\u88fd\u5f8c\uff0c\u65b0\u578b\u51a0\u72c0\u75c5\u6bd2\u85c9\u7531\u98db\u6cab\u7684\u65b9\u5f0f\uff0c\u5728\u5404\u500b\u5bbf\u4e3b\u9593\u50b3\u64ad\uff0c\u540c\u6642\u8ddf\u8457\u73fe\u4ee3\u5316\u904b\u8f38\u4e00\u8d77\u5468\u904a\u5217\u570b\uff0c\u50b3\u64ad\u7684\u80fd\u529b\u53ef\u80fd\u6bd4\u7121\u9060\u5f17\u5c46\u7684\u7db2\u8def\u66f4\u52dd\u4e00\u7c4c\u3002<\/p>\n

\u4eba\u985e\u91dd\u5c0d\u65b0\u578b\u51a0\u72c0\u75c5\u6bd2\u7814\u767c\u75ab\u82d7\u8207\u4e2d\u548c\u6027\u6297\u9ad4\uff0c\u4ee5\u75c5\u6bd2\u8868\u9762\u5206\u5e03\u7684\u68d8\u86cb\u767d\u6216\u4e3b\u8981\u548c ACE2 \u53d7\u9ad4\u7d50\u5408\u7684 RBD \u70ba\u6a19\u7684\u9032\u884c\u8a2d\u8a08\u3002\u75ab\u82d7\u8a98\u5c0e\u7684\u6297\u9ad4\u8207\u6cbb\u7642\u6027\u6297\u9ad4\uff0c\u5927\u591a\u662f\u7528\u4f86\u963b\u65b7\u75c5\u6bd2\u8207\u5bbf\u4e3b\u7d30\u80de ACE2 \u7684\u7d50\u5408\uff0c\u6291\u5236\u75c5\u6bd2\u9032\u5165\u7d30\u80de\uff0c\u9019\u4e9b\u6297\u9ad4\u4e5f\u7a31\u4e4b\u70ba\u300c\u4e2d\u548c\u6027\u6297\u9ad4\u300d\u3002\u4e2d\u548c\u6027\u6297\u9ad4\u53ef\u4ee5\u964d\u4f4e\u75c5\u6bd2\u5728\u9ad4\u5167\u8907\u88fd\u7684\u6578\u91cf\uff0c\u56e0\u800c\u907f\u514d\u75be\u75c5\u60e1\u5316\u3001\u52a0\u901f\u75c5\u6bd2\u5728\u9ad4\u5167\u7684\u6e05\u9664\u4f7f\u60a3\u8005\u5eb7\u5fa9\u3002<\/p>\n

\u4f46\u65b0\u578b\u51a0\u72c0\u75c5\u6bd2\u5982\u4f55\u907f\u958b\u9019\u4e9b\u4e2d\u548c\u6027\u6297\u9ad4\u7684\u7d50\u5408\u5462?\u9996\u5148\u6211\u5011\u5f97\u5148\u8ac7\u8ac7\u65b0\u578b\u51a0\u72c0\u75c5\u6bd2\u7684\u7a81\u8b8a\u7387\u3002\u65b0\u578b\u51a0\u72c0\u75c5\u6bd2\u651c\u5e36 RNA \u4f9d\u8cf4\u6027 RNA \u805a\u5408\u9176\uff0c\u4f5c\u70ba\u8907\u88fd\u75c5\u6bd2 RNA \u57fa\u56e0\u9ad4\u8207\u8f49\u9304\u3001\u8f49\u8b6f\u75c5\u6bd2\u86cb\u767d\u8cea\uff1bRNA \u805a\u5408\u9176\u64c1\u6709\u6bd4 DNA \u805a\u5408\u9176\u8f03\u9ad8\u7684\u7a81\u8b8a\u7387\uff0c\u56e0\u6b64\uff0cRNA \u75c5\u6bd2\u76f8\u8f03 DNA \u75c5\u6bd2\uff0c\u5148\u5929\u4e0a\u5c31\u6bd4\u8f03\u5bb9\u6613\u7a81\u8b8a\u3002\u65b0\u578b\u51a0\u72c0\u75c5\u6bd2\u56e0\u70ba\u611f\u67d3\u5bbf\u4e3b\u6578\u773e\u591a\uff0c\u518d\u642d\u914d RNA \u805a\u5408\u9176\u7684\u7a81\u8b8a\u7387\uff0c\u9020\u6210\u5f9e 2019 \u5e74\u5e95\u958b\u59cb\u5f9e\u6b66\u6f22\u75c5\u6bd2\u682a\uff0c\u4e0d\u65b7\u6709\u65b0\u8b8a\u7570\u682a\u7522\u751f\uff0c\u5305\u542b\uff1a2021 \u5e74\u6d41\u884c\u7684 Alpha\u3001Beta\u3001Gamma\u3001Delta\uff0c\u4ee5\u53ca 2021 \u5e74\u5e95\u6025\u901f\u6210\u9577\u7684 Omicron\uff0cOmicron \u4e5f\u4e0d\u65b7\u7684\u6709\u5c0f\u8b8a\u7570\uff0c\u4f7f\u5f97 Omicron \u7cfb\u5217\u7684\u4e9e\u8b8a\u7570\u682a\u5728 2022 \u5e74\u65bc\u5404\u570b\u904d\u5730\u958b\u82b1\u3002<\/p>\n

\u6297\u9ad4\u7684\u61c9\u7528\uff1a\u6297\u9ad4\u85e5\u7269<\/strong><\/p>\n

\u55ae\u682a\u6297\u9ad4\u85e5\u7269\u65e9\u5df2\u5ee3\u6cdb\u61c9\u7528\u65bc\u4eba\u985e\u75be\u75c5\u7684\u6cbb\u7642\uff0c\u91dd\u5c0d\u65b0\u578b\u51a0\u72c0\u75c5\u6bd2\uff0cBamlanivimab \u548c REGEN-COV\uff08Casirivimab + Imdevimab\uff09\u5728 2020 \u5e74 11 \u6708\u7372\u5f97\u7f8e\u570b\u98df\u54c1\u85e5\u7269\u7ba1\u7406\u5c40\uff08FDA\uff09\u7684\u7dca\u6025\u4f7f\u7528\u6388\u6b0a\uff08EUA\uff09\u5f8c\uff0c\u5373\u6295\u5165\u65b0\u578b\u51a0\u72c0\u75c5\u6bd2\u7684\u6cbb\u7642\uff0c\u81f3\u4eca\u5171\u6709 8 \u682a\u6297\u9ad4\u7372\u5f97\u7f8e\u570b FDA EUA\uff0c\u7f8e\u570b\u653f\u5e9c\u5171\u63a1\u8cfc\u8d85\u904e 550 \u842c\u5291\uff0c\u5c0d\u65bc\u6cbb\u7642\u65b0\u578b\u51a0\u72c0\u75c5\u6bd2\u548c\u62ef\u6551\u751f\u547d\u6709\u5353\u8d8a\u7684\u8ca2\u737b\u3002\u5728\u5f8c\u75ab\u60c5\u6642\u4ee3\uff0c\u65b0\u578b\u51a0\u72c0\u75c5\u6bd2\u7684\u75ab\u82d7\u6709\u9ad8\u6bd4\u4f8b\u7684\u63a5\u7a2e\u7387\uff0c\u4ee5\u53ca\u5c0f\u5206\u5b50\u75c5\u6bd2\u85e5\u7269\u4e0a\u5e02\uff0c\u5c0d\u65bc\u6cbb\u7642\u6027\u6297\u9ad4\u7684\u767c\u5c55\u6709\u5287\u70c8\u7684\u5f71\u97ff\u3002\u7136\u800c\u6839\u64da\u7814\u7a76\u5831\u5c0e\uff0c\u7f8e\u570b\u7d04\u6709 700 \u842c\u4eba\uff0c\u82f1\u570b\u7d04\u6709 50 \u842c\u4eba\u88ab\u8a8d\u70ba\u514d\u75ab\u529f\u80fd\u4f4e\u4e0b\uff0c\u56e0\u6b64\u5c0d\u65b0\u578b\u51a0\u72c0\u75c5\u6bd2\u75ab\u82d7\u7684\u514d\u75ab\u53cd\u61c9\u8f03\u4f4e\uff0c\u8a98\u5c0e\u7522\u751f\u7684\u6297\u9ad4\u6548\u50f9\u4e0d\u8db3\uff0c\u53ef\u80fd\u5bb9\u6613\u9020\u6210\u7a81\u7834\u6027\u611f\u67d3\u3002\u6cbb\u7642\u6027\u6297\u9ad4\u65bc\u9ad4\u5167\u9577\u6548\u7684\u534a\u8870\u671f\u6709\u6a5f\u6703\u5f4c\u88dc\u6b64\u7f3a\u53e3\uff0c\u64d4\u4efb\u9810\u9632\u7684\u89d2\u8272\uff0c\u4f8b\u5982\uff1aREGEN-COV \u548c Evusheld \uff08Cilgavimab + Tixagevimab\uff09\u7528\u65bc\u9810\u9632\u4e2d\u91cd\u75c7\u7684\u4fdd\u8b77\u6548\u679c\u5206\u5225\u6709 81% \u548c 83%\uff0c\u56e0\u6b64\u7f8e\u570b FDA \u7d66\u4e88\u7528\u65bc\u9810\u9632\u7684 EUA\u3002 Omicron BA.5 \u8b8a\u7570\u682a\u5728 2022 \u5e74\u6210\u70ba\u4e16\u754c\u4e3b\u8981\u6d41\u884c\u682a\uff0c\u56e0\u5728\u68d8\u86cb\u767d\u9ad8\u5ea6\u7684\u7a81\u8b8a\uff0c\u4f7f\u5f97\u8a31\u591a EUA \u6838\u53ef\u4f7f\u7528\u4e4b\u6cbb\u7642\u6027\u6297\u9ad4\u5931\u53bb\u91dd\u5c0d Omicron \u7684\u4e2d\u548c\u80fd\u529b\uff08IC50 >10 \u03bc g\/mL\uff09\u3002\u56e0\u6b64\u7f8e\u570b FDA \u66f4\u56e0\u6b64\u65bc 2022 \u4e0a\u534a\u5e74\uff0c\u66ab\u505c\u4f7f\u7528 4 \u6b3e EUA \u4e4b\u6cbb\u7642\u6027\u6297\u9ad4\u3002\u986f\u793a\uff0c\u7814\u767c\u5ee3\u6548\u6027\u4e14\u80fd\u4e2d\u548c\u7576\u524d\u8b8a\u7570\u682a\u4e4b\u6cbb\u7642\u6027\u6297\u9ad4\u662f\u91cd\u8981\u7684\u91ab\u7642\u9700\u6c42\u3002<\/p>\n

\u672c\u9662\u751f\u91ab\u8f49\u8b6f\u7814\u7a76\u4e2d\u5fc3\u5433\u6f22\u5fe0\u4e3b\u4efb\u5be6\u9a57\u5ba4\u5718\u968a\u5229\u7528\u8102\u8cea\u5948\u7c73\u7c92\u5b50\uff08LNP\uff09\u5305\u8986\u65b0\u578b\u51a0\u72c0\u75c5\u6bd2\u68d8\u86cb\u767d\u7684 mRNA \u8207\u5c0f\u9f20\u878d\u5408\u7624\u6280\u8853\uff0c\u4f86\u88fd\u5099\u5c0d\u6297\u65b0\u578b\u51a0\u72c0\u75c5\u6bd2 RBD \u7684\u55ae\u682a\u6297\u9ad4\u3002\u6b64 LNP-mRNA \u6280\u8853\u53ef\u4ee5\u7bc0\u7701\u50b3\u7d71\u91cd\u7d44\u86cb\u767d\u6297\u539f\u88fd\u4f5c\u751f\u7522\u7684\u6642\u9593\uff0c\u4e26\u4e14\u66f4\u9069\u7528\u65bc\u56f0\u96e3\u751f\u7522\u7684\u6297\u539f\u86cb\u767d\uff0c\u4f8b\u5982\uff1a\u819c\u86cb\u767d\u3001\u5927\u5206\u5b50\u91cf\u3001\u9ad8\u758f\u6c34\u6027\u86cb\u767d\u7b49\uff0c\u7be9\u9078\u51fa 5 \u682a\u53ef\u4ee5\u8fa8\u8a8d Omicron RBD \u7684\u55ae\u682a\u6297\u9ad4\uff0c\u4e26\u4ee5\u507d\u6162\u75c5\u6bd2\u8b49\u5be6\u5176\u53ef\u5ee3\u6cdb\u6027\u5730\u4e2d\u548c\u65b0\u578b\u51a0\u72c0\u75c5\u6bd2\u8b8a\u7570\u682a\uff0c\u5305\u542b\uff1aAlpha\u3001Beta\u3001Gamma\u3001Kappa\u3001Delta\u3001Omicron\u3001BA.1 \u8207 BA.2\u3002<\/p>\n

\u5be6\u9a57\u5718\u968a\u9032\u4e00\u6b65\u5c07\u5176\u4e2d\u5169\u682a\u904b\u7528\u6297\u9ad4\u5de5\u7a0b\u6280\u8853\u9032\u884c\u6297\u9ad4\u4eba\u6e90\u5316\uff0c\u6e2c\u8a66\u5f8c\uff0c\u6210\u529f\u5730\u5ef6\u7e8c\u5c0d BA.2 \u507d\u6162\u75c5\u6bd2\u7684\u826f\u597d\u6291\u5236\u80fd\u529b\uff08\u5716\u4e00\u4e0a\uff09\u3002\u53e6\u4e00\u65b9\u9762\u4f7f\u7528\u4eba\u985e\u55ae\u4e00 B \u7d30\u80de\u6297\u9ad4\u6280\u8853\uff0c\u5f9e\u63a5\u7a2e\u75ab\u82d7\u6216\u662f\u611f\u67d3\u75ca\u7652\u5f8c\u6350\u8d08\u8005\u7684\u8840\u6db2\u5206\u96e2\u7279\u5b9a\u8b8a\u7570\u682a\u7684\u4e2d\u548c\u6027\u6297\u9ad4\uff08\u5716\u4e00\u4e0b\uff09\u3002\u5be6\u9a57\u5718\u968a\u7be9\u9078\u51fa\u5c0d\u4e00\u7cfb\u5217\u5c0d Omicron \u4e9e\u8b8a\u7570\u682a\u7684\u4e2d\u548c\u6027\u6297\u9ad4\uff0c\u5305\u542b BA.1\u3001BA.2\u3001BA.4\/5\u3001BQ.1.1\u3001BF.7\u3001\u548c XBB.1\u3002\u5728 2023 \u5e74\u521d\uff0cOmicron BQ \u5df2\u8d85\u8d8a BA.5 \u6210\u70ba\u5168\u7403\u7684\u6d41\u884c\u8b8a\u7570\u682a\u3002BQ \u8ddf BA.5 \u76f8\u6bd4\uff0c\u5728 RBD \u4e0a\u591a\u4e86 K444T \u8207 M406K \u5169\u500b\u7a81\u8b8a\u70ba\u9ede\uff0c\u6210\u529f\u9003\u812b\u4e86 Bebtelovimab \u6cbb\u7642\u6027\u6297\u9ad4\u7684\u7d50\u5408\u3002<\/p>\n

\"\u3010\u5c08\u6b04\u3011\u7576\u4eba\u985e\u9047\u898b\u65b0\u578b\u51a0\u72c0\u75c5\u6bd2

\u25b2\u5716\u4e00\uff1a\u6cbb\u7642\u6027\u6297\u9ad4<\/p><\/div>\n

\u6297\u9ad4\u7684\u61c9\u7528\uff1a\u8a3a\u65b7\u8a66\u5291<\/strong><\/p>\n

\u82e5\u80fd\u5feb\u901f\u3001\u5927\u898f\u6a21\u800c\u7cbe\u6e96\u5730\u7be9\u6aa2\u51fa\u53d7\u65b0\u578b\u51a0\u72c0\u75c5\u6bd2\u611f\u67d3\u8005\uff0c\u6709\u52a9\u65bc\u75c5\u60a3\u7684\u9694\u96e2\u8207\u6cbb\u7642\uff0c\u4fbf\u53ef\u4ee5\u9650\u5236\u75ab\u60c5\u767c\u5c55\u3002\u5074\u5411\u6d41\u9ad4\u514d\u75ab\u5c64\u6790\u6cd5\uff08LFIA, lateral flow immunochromatographic assay\uff09\u767c\u5c55\u5c0d\u6297\u539f\u6216\u6297\u9ad4\u9032\u884c\u7684\u6aa2\u6e2c\u7684\u8a3a\u65b7\u8a66\u5291\uff0c\u5feb\u901f\u4e14\u4e0d\u9700\u7279\u6b8a\u5100\u5668\u9032\u884c\u5206\u6790\uff0c\u9069\u5408\u904b\u7528\u65bc\u7b2c\u4e00\u7dda\u9632\u75ab\u4e4b\u5927\u91cf\u7be9\u6aa2\u3002\u65b0\u578b\u51a0\u72c0\u75c5\u6bd2\u4e4b\u6838\u6bbc\u86cb\u767d\uff08NP\uff09\u5728\u75c5\u6bd2\u9846\u7c92\u4e2d\uff0c\u626e\u6f14\u7a69\u5b9a RNA \u57fa\u56e0\u9ad4\u7684\u89d2\u8272\uff0c\u56e0\u6b64\u5e8f\u5217\u8f03\u5c11\u7a81\u8b8a\uff0c\u4e26\u4e14\u53ef\u4ee5\u5728\u611f\u67d3\u8005\u9f3b\u54bd\u8655\u5927\u91cf\u88ab\u5075\u6e2c\uff0c\u662f\u5f88\u7406\u60f3\u7684\u5075\u6e2c\u6a19\u7684\u3002\u5433\u6f22\u5fe0\u5be6\u9a57\u5ba4\u5718\u968a\u5728\u75ab\u60c5\u5927\u6d41\u884c\u521d\u671f\uff0c\u5373\u88fd\u5099\u591a\u7a2e\u5c0d\u6297\u6838\u6bbc\u86cb\u767d\u7684\u55ae\u682a\u6297\u9ad4\uff0c\u7528\u4ee5\u958b\u767c\u65b0\u578b\u51a0\u72c0\u75c5\u6bd2\u6297\u539f\u5feb\u7be9\u8207\u8840\u6e05\u6297\u9ad4\u5feb\u7be9\uff08\u5982\u5716\u4e8c\uff09\u3002\u8207\u6148\u6fdf\u5927\u5b78\u5408\u4f5c\u958b\u767c\u4e4b\u65b0\u578b\u51a0\u72c0\u75c5\u6bd2\u8840\u6e05\u96d9\u6297\u9ad4 IgG\/IgM \u5feb\u7be9\uff0c\u65bc 2020 \u5e74\u901a\u904e\u53f0\u7063\u885b\u751f\u798f\u5229\u90e8\u98df\u54c1\u85e5\u7269\u7ba1\u7406\u7f72 EUA \u5f8c\u4fbf\u7a4d\u6975\u9032\u884c\u570b\u969b\u4eba\u9053\u6551\u63f4\uff0c\u843d\u5be6\u300cTaiwan can help\u300d\u3002\u53e6\u5916\uff0c\u5718\u968a\u4e5f\u7a4d\u6975\u7814\u767c\u6297\u9ad4\u914d\u5c0d\u3001\u9748\u654f\u5ea6\u8207\u7279\u7570\u6027\u6e2c\u8a66\uff0c\u4ee5\u53ca\u81e8\u5e8a\u8a66\u9a57\u5f8c\uff0c\u65bc 2021 \u5e74 7 \u6708\u5b8c\u6210\u7814\u6e96\u65b0\u578b\u51a0\u72c0\u75c5\u6bd2\u6297\u539f\u5feb\u901f\u6aa2\u9a57\u8a66\u5291\uff08\u9632\u75ab\u5c08\u6848\u88fd\u9020\u6838\u51c6\u6587\u865f\uff1a1106810393\uff09\uff0c\u6574\u9ad4\u8a66\u5291\u6e96\u78ba\u7387\u8207\u9748\u654f\u5ea6\u7686 \u2265 99%\u3002\u65bc Omicron \u75c5\u60a3\u9f3b\u54bd\u6aa2\u9ad4\u4e2d\uff0c\u7814\u6e96\u5feb\u7be9\u53ef\u5075\u6e2c Ct \u2264 32.6 \u4e4b\u81e8\u5e8a\u6aa2\u9ad4\uff0c\u986f\u793a\u7814\u6e96\u6297\u539f\u5feb\u901f\u7be9\u6aa2\u8a66\u5291\u5c0d\u771f\u5be6\u4e4b Omicron \u8b8a\u7570\u682a\u826f\u597d\u7684\u5075\u6e2c\u654f\u611f\u5ea6\uff0c\u53ef\u5075\u6e2c\u5305\u542b Omicron \u8207\u5176\u4ed6\u8b8a\u7570\u682a\uff0c\u986f\u793a\u6b64\u8a66\u5291\u4e0d\u53d7\u7a81\u8b8a\u682a\u57fa\u56e0\u5e8f\u5217\u6539\u8b8a\u800c\u7522\u751f\u5e72\u64fe\u3002\u7279\u7570\u6027\u5206\u6790\u6307\u51fa\uff0c\u6b64\u8a66\u5291\u4e5f\u4e26\u4e0d\u6703\u8fa8\u8a8d\u5230 2003 \u5e74\u6d41\u884c\u7684 SARS \u8207\u5176\u4ed6\u5e38\u898b\u547c\u5438\u9053\u75c5\u539f\u83cc\u3002\u8207\u7f8e\u570b EUA \u91ab\u8b77\u4eba\u58eb\u4f7f\u7528\u4ee5\u76ee\u8996\u9032\u884c\u5224\u8b80\u7684\u65b0\u578b\u51a0\u72c0\u75c5\u6bd2\u6297\u539f\u5feb\u7be9\u76f8\u8f03\uff0c\u5176\u5075\u6e2c\u9748\u654f\u5ea6\u6392\u540d\u70ba\u7b2c 6 \u540d\uff0c\u986f\u793a\u570b\u5167\u7814\u767c\u80fd\u529b\u4e26\u4e0d\u4e9e\u65bc\u570b\u969b\u3002<\/p>\n

\"\"

\u25b2\u5716\u4e8c\uff1a\u8a3a\u65b7\u8a66\u5291<\/p><\/div>\n

\u6b7b\u4ea1\u8207\u52a0\u5195<\/strong><\/p>\n

\u4ee5\u75c5\u6bd2\u7e41\u884d\u7684\u89d2\u5ea6\u800c\u8a00\uff0c\u65b0\u51a0\u75c5\u6bd2\u582a\u7a31\u6f14\u5316\u754c\u7684\u7ff9\u695a\u3002\u4e0d\u540c\u8b8a\u7570\u682a\uff0c\u5c24\u5176\u5728\u4e2d\u548c\u6027\u6297\u9ad4\u8fa8\u8b58\u7684\u68d8\u86cb\u767d\u4e0a\u7522\u751f\u7a81\u8b8a\uff0c\u9020\u6210\u4e2d\u548c\u6027\u6297\u9ad4\u7121\u6cd5\u7d50\u5408\u8207\u8fa8\u8b58\uff0c\u5f77\u5f7f\u5b8c\u7f8e\u7684\u6613\u5bb9\u8853\uff0c\u8eb2\u907f\u5bbf\u4e3b\u514d\u75ab\u7cfb\u7d71\u7684\u8ffd\u6bba\u3002\u56e0\u6b64\u5728\u5168\u7403\u6b61\u6b23\u9f13\u821e\u5730\u8a8d\u70ba\u65bd\u6253\u7684\u75ab\u82d7\u3001\u6cbb\u7642\u6027\u6297\u9ad4\u80fd\u6709\u6548\u7684\u6291\u5236\u65b0\u578b\u51a0\u72c0\u75c5\u6bd2\u611f\u67d3\u7684\u540c\u6642\uff0c\u75c5\u6bd2\u7a81\u8b8a\u6b63\u7121\u8072\u919e\u91c0\u8457\uff0c\u76f4\u5230\u6210\u70ba\u4e0b\u4e00\u500b\u6210\u529f\u9003\u812b\u7375\u6bba\u7684\u8b8a\u7570\u682a\u3002\u65b0\u51a0\u75c5\u6bd2\u5927\u6d41\u884c\u81f3\u4eca\u9020\u6210\u8d85\u904e 670 \u842c\u4eba\u6b7b\u4ea1\uff0c\u7136\u800c\u81ea\u7136\u611f\u67d3\u7684\u5eb7\u5fa9\u8005\u6216\u75ab\u82d7\u63a5\u7a2e\u8005\uff0c\u9ad4\u6db2\u8207\u7d30\u80de\u514d\u75ab\u7372\u5f97\u9632\u8b77\u529b\u91cf\u7684\u63d0\u5347\uff1b\u53e6\u4e00\u65b9\u9762\u4ea6\u4fc3\u9032\u4eba\u985e\u91ab\u7642\u751f\u6280\u7684\u9032\u6b65\uff0c\u4ee5\u56e0\u61c9\u75c5\u6bd2\u7684\u5feb\u901f\u7a81\u8b8a\u4ee5\u53ca\u65b0\u8208\u75c5\u6bd2\u7684\u5d1b\u8d77\u3002\u7d9c\u89c0\u800c\u8a00\uff0c\u9019\u672a\u5617\u4e0d\u662f\u65b0\u578b\u300c\u51a0\u72c0\u300d\u75c5\u6bd2\u5c0d\u4eba\u985e\u514d\u75ab\u8207\u751f\u6280\u7684\u53e6\u4e00\u7a2e\u300c\u52a0\u5195\u300d\u3002<\/p>\n","protected":false},"excerpt":{"rendered":"

\u81ea\u958b\u5929\u95e2\u5730\u4ee5\u4f86\uff0c\u4eba\u985e\u7d93\u6b77\u4e0d\u540c\u6642\u671f\u751f\u6d3b\u578b\u614b\u7684\u8f49\u63db\uff0c\u7121\u8ad6\u662f\u72e9\u7375\u63a1\u96c6\u3001\u8fb2\u696d\u751f\u6d3b\uff0c\u9762\u5c0d\u7121\u6240\u4e0d\u5728\u7684\u75c5\u83cc\u4e14\u91ab\u85e5\u5c1a\u672a\u767c\u5c55\u4e4b\u6642 […]<\/p>\n","protected":false},"author":1,"featured_media":30031,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[991,983],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/newsletter.sinica.edu.tw\/wp-json\/wp\/v2\/posts\/30025"}],"collection":[{"href":"https:\/newsletter.sinica.edu.tw\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/newsletter.sinica.edu.tw\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/newsletter.sinica.edu.tw\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/newsletter.sinica.edu.tw\/wp-json\/wp\/v2\/comments?post=30025"}],"version-history":[{"count":1,"href":"https:\/newsletter.sinica.edu.tw\/wp-json\/wp\/v2\/posts\/30025\/revisions"}],"predecessor-version":[{"id":30068,"href":"https:\/newsletter.sinica.edu.tw\/wp-json\/wp\/v2\/posts\/30025\/revisions\/30068"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/newsletter.sinica.edu.tw\/wp-json\/wp\/v2\/media\/30031"}],"wp:attachment":[{"href":"https:\/newsletter.sinica.edu.tw\/wp-json\/wp\/v2\/media?parent=30025"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/newsletter.sinica.edu.tw\/wp-json\/wp\/v2\/categories?post=30025"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/newsletter.sinica.edu.tw\/wp-json\/wp\/v2\/tags?post=30025"}],"curies":[{"name":"wp","href":"https:\/api.w.org\/{rel}","templated":true}]}}